Skip to main content

Series B Neuroscience Companies

Explore 16 neuroscience startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
16
Total Funding
$731.4M
Avg Funding
$45.7M
Cities
15

Export 16 Series B Neuroscience Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Leiden, The Netherlands
$12.3M
raised

Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.

Jun 2024
Series B

Founder Contacts

30,000+ verified contacts

South San Francisco, United States
$73.8M
raised

Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.

Jun 2026
Series B

Founder Contacts

30,000+ verified contacts

Tokyo, Japan
$22.9M
raised

Aculys Pharma is a pharmaceutical company that develops drugs and innovative medical treatments for neurological and psychiatric disorders.

Mar 2022
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$123.0M
raised

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

Mar 2023
Series B

Founder Contacts

30,000+ verified contacts

Redmond, United States
$26.0M
raised

Cadence Neuroscience is an early-stage company developing medical device therapies for epilepsy.

Feb 2023
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 16 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$39.0M
raised

SEVARO is a healthcare technology company that provides teleneurology services for patients with neurological disorders.

Sep 2025
Series B

Founder Contacts

30,000+ verified contacts

Bloomington, United States
$26.6M
raised

Fasikl is a neuro-AI company that creates interfaces for the nervous system.

Sep 2025
Series B

Founder Contacts

30,000+ verified contacts

Boston, United States
$25.0M
raised

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Sep 2025
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom
$67.5M
raised

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

Sep 2025
Series B

Founder Contacts

30,000+ verified contacts

Oss, The Netherlands
$89.7M
raised

Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.

Dec 2024
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 16 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Ohio, United States
$12.3M
raised

Neuro Therapia is developing new therapies for diseases with an underlying component of neuroinflammation.

Aug 2024
Series B

Founder Contacts

30,000+ verified contacts

Genîve, Switzerland
$13.6M
raised

STALICLA is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders.

Jan 2024
Series B

Founder Contacts

30,000+ verified contacts

Watertown, United States
$86.6M
raised

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.

May 2023
Series B

Founder Contacts

30,000+ verified contacts

Manchester, United Kingdom
$7.0M
raised

Arctic Shores is a behavior-based assessments provider for employers and companies.

Jan 2023
Series B

Founder Contacts

30,000+ verified contacts

Whitefish, United States
$35.0M
raised

Neuro-ID provides behavioral analytics identity solutions for banks, fintech, and insurance industries.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 16 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Düsseldorf, Germany
$71.0M
raised

Resolve Biosciences is a biotechnology research company for molecular cartography.

Oct 2022
Series B

Founder Contacts

30,000+ verified contacts

Ready to Connect with Series B Neuroscience Startups?

Get verified founder emails, funding details, and company data for 16 series b neuroscience companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked